ClinicalTrials.Veeva

Menu
C

Clinical Research Philadelphia | Philadelphia, PA

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Amlitelimab
progestin
JNJ-77242113
Ustekinumab
SAR444656
Rimegepant

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

8 of 12 total trials

A Phase 2 Study to Evaluate the Efficacy and Safety of SAR444656 Compared With Placebo in Adult Participants With Moderate to Severe Hidradenitis Suppurativa (ZEN)

This is a parallel, Phase 2, 3-arm study to evaluate the efficacy, safety, PK, and biological effects of SAR444656 compared with placebo in adult par...

Active, not recruiting
Hidradenitis Suppurativa
Drug: Placebo
Drug: SAR444656 (KT-474)

The purpose of this study is to establish the efficacy, safety and tolerability of barzolvolimab in adult participants with Chronic Spontaneous Urtic...

Enrolling
Chronic Spontaneous Urticaria
Biological: barzolvolimab
Biological: Matching placebo

The main purpose of this study is to assess how well JNJ-77242113 works when compared to placebo and ustekinumab in participants with moderate to sev...

Active, not recruiting
Plaque Psoriasis
Drug: Ustekinumab
Drug: Matching Placebo to Ustekinumab

This is a parallel group, Phase 3, multinational, multicenter, randomized, double blind, placebo-controlled, 3-arm monotherapy study for treatment of...

Active, not recruiting
Dermatitis Atopic
Drug: Amlitelimab
Drug: Placebo

This is a parallel group, Phase 3, multinational, multicenter, randomized, double-blind, placebo-controlled, 3-arm study for treatment of participant...

Enrolling
Dermatitis Atopic
Drug: Amlitelimab
Drug: Topical corticosteroids

This is an open-label, Phase 2/Phase 3, long-term extension study for treatment of participants of previous amlitelimab clinical trials in moderate t...

Enrolling
Dermatitis Atopic
Drug: Oral corticosteroids
Drug: Amlitelimab

The purpose of this study is to evaluate the clinical efficacy and safety of nipocalimab in participants with moderate to severe Sjogren's disease (S...

Enrolling
Sjogrens Syndrome
Drug: Placebo
Drug: Standard of care treatment

The Sponsor is developing a progestin-only contraceptive transdermal system (patch).The main purpose of this study is to look at how safe the study p...

Enrolling
Female Contraception
Drug: Transdermal system containing progestin

Trial sponsors

Sanofi logo
Janssen (J&J Innovative Medicine) logo
Pfizer logo
Allergan logo
Celldex Therapeutics logo
K
Mylan logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems